Senate Hearing on 2023 NIH Budget Request
January 1, 2021
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This hearing sets the stage for federal funding allocations that determine the scope of medical research, public health initiatives, and disease treatment development for the upcoming fiscal year.
Potentially affected actors named in the source documents. Mention is not a position.
Biomedical researchers
The level of federal funding approved for the NIH directly impacts the resources and grants available for research projects.
Patients with chronic diseases
Federal research priorities influence the development of new treatments and cures for conditions like Alzheimer's and COVID-19.
Last recorded activity January 1, 2021.
Next step not available in the current record.
Summary
Key Facts
- The hearing reviewed the Biden Administration's fiscal year 2023 budget request for the National Institutes of Health (NIH).
- The U.S. recorded 107,000 overdose deaths in a single year.
- Opioid deaths in Washington State increased by two-thirds in 2021.
- Funding for Alzheimer's research has increased six-fold since 2015.
- The National Alzheimer Project Act established a 2025 target date for addressing the disease.
- The Advanced Research Projects Agency for Health (ARPA-H) was established in a previous bipartisan funding bill.
- The Prevent Pandemics Act is currently under consideration to define the long-term structure of ARPA-H.
- The subcommittee discussed the balance of funding between existing NIH institutes and the new ARPA-H agency.
Frequently Asked Questions
What is the purpose of ARPA-H?
Why is the committee concerned about the NIH budget?
Why It Matters
This hearing sets the stage for federal funding allocations that determine the scope of medical research, public health initiatives, and disease treatment development for the upcoming fiscal year.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Shift toward high-risk research
The creation of ARPA-H signals a structural shift in how the federal government funds medical innovation, moving toward a more independent, agile model.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance85How much this matters to a regular citizen
- Controversy30Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz40Current news / social attention level
Publisher tools